Drupal.behaviors.print = function(context) {window.print();window.close();}>
OGT Acquires Sense Proteomic
March 17, 2009
OGT Acquires Sense Proteomic
By a GenomeWeb staff reporter
OGT gains technologies for biomarker identification, which could be used for therapeutic monitoring.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
OGT's Protein Array at Heart of Sengenics Deal, Test-Development Programs
March 19, 2013 / BioArray News
OGT, Aushon, and Gentel Ink Separate Deals to Bolster Their Place in Protein-Array Market
March 17, 2009 / BioArray News
OGT to Use Protein, MiRNA Platforms in Biomarker-Discovery Pact with Abcodia
November 8, 2011 / BioArray News
GIS, Sengenics Partner on Biomarkers for Early Detection of Cancer
May 29, 2013 / GenomeWeb Daily News
Opko Health Revamping Peptoid-Based Diagnostic Platform, Prepping Alzheimer's Test for Market
July 27, 2012 / ProteoMonitor